These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 7903872

  • 1. Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers.
    Westendorp RG, Draijer R, Meinders AE, van Hinsbergh VW.
    J Vasc Res; 1994; 31(1):42-51. PubMed ID: 7903872
    [Abstract] [Full Text] [Related]

  • 2. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells.
    Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VW.
    Circ Res; 1995 Feb; 76(2):199-208. PubMed ID: 7834830
    [Abstract] [Full Text] [Related]

  • 3. Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers.
    Hempel A, Noll T, Muhs A, Piper HM.
    Am J Physiol; 1996 Apr; 270(4 Pt 2):H1264-71. PubMed ID: 8967365
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of ularitide acetate and other bronchorelaxing substances on the thrombin-induced permeability raise of human endothelial cell monolayers.
    Korn C, Neidlein R, Strein K, Wilhelms OH.
    Arzneimittelforschung; 1998 Mar; 48(3):251-8. PubMed ID: 9553682
    [Abstract] [Full Text] [Related]

  • 5. Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
    Renowden S, Edwards DH, Griffith TM.
    Br J Pharmacol; 1992 Jun; 106(2):348-53. PubMed ID: 1327377
    [Abstract] [Full Text] [Related]

  • 6. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
    Toyoshima H, Nasa Y, Hashizume Y, Koseki Y, Isayama Y, Kohsaka Y, Yamada T, Takeo S.
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):543-51. PubMed ID: 9781922
    [Abstract] [Full Text] [Related]

  • 7. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H, Yoshikawa T, Hisayama T, Takeuchi S.
    Eur J Pharmacol; 1992 Jan 07; 210(1):61-8. PubMed ID: 1350988
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP.
    Kubes P.
    Am J Physiol; 1993 Dec 07; 265(6 Pt 2):H1909-15. PubMed ID: 8285229
    [Abstract] [Full Text] [Related]

  • 9. Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability.
    Hempel A, Noll T, Bach C, Piper HM, Willenbrock R, Höhnel K, Haller H, Luft FC.
    Am J Physiol; 1998 Nov 07; 275(5):H1818-25. PubMed ID: 9815090
    [Abstract] [Full Text] [Related]

  • 10. Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMP.
    Altiok N, Fredholm BB.
    Neurochem Int; 1992 Sep 07; 21(2):209-13. PubMed ID: 1284620
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of inositol 1,4,5-trisphosphate formation by cyclic GMP in cultured aortic endothelial cells of the pig.
    Lang D, Lewis MJ.
    Br J Pharmacol; 1991 Jan 07; 102(1):277-81. PubMed ID: 1646060
    [Abstract] [Full Text] [Related]

  • 12. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
    Marczin N, Ryan US, Catravas JD.
    Am J Physiol; 1992 Jul 07; 263(1 Pt 1):L113-21. PubMed ID: 1379001
    [Abstract] [Full Text] [Related]

  • 13. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability.
    Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweit T.
    Am J Physiol; 1996 Mar 07; 270(3 Pt 1):C778-85. PubMed ID: 8638657
    [Abstract] [Full Text] [Related]

  • 14. Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP.
    Buchan KW, Martin W.
    Br J Pharmacol; 1991 Oct 07; 104(2):361-6. PubMed ID: 1665733
    [Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells.
    Klinger JR, Warburton R, Carino GP, Murray J, Murphy C, Napier M, Harrington EO.
    Exp Cell Res; 2006 Feb 15; 312(4):401-10. PubMed ID: 16360149
    [Abstract] [Full Text] [Related]

  • 16. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.
    Wright IK, Amirchetty-Rao S, Kendall DA.
    Br J Pharmacol; 1994 Aug 15; 112(4):1146-50. PubMed ID: 7524992
    [Abstract] [Full Text] [Related]

  • 17. Platelet cGMP, but not cAMP, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium.
    Venturini CM, Weston LK, Kaplan JE.
    Am J Physiol; 1992 Aug 15; 263(2 Pt 2):H606-12. PubMed ID: 1324614
    [Abstract] [Full Text] [Related]

  • 18. Dual role of cGMP in modulation of macromolecule permeability of aortic endothelial cells.
    Hölschermann H, Noll T, Hempel A, Piper HM.
    Am J Physiol; 1997 Jan 15; 272(1 Pt 2):H91-8. PubMed ID: 9038926
    [Abstract] [Full Text] [Related]

  • 19. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ.
    Br J Pharmacol; 2003 Aug 15; 139(7):1289-96. PubMed ID: 12890708
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP.
    Lofton CE, Newman WH, Currie MG.
    Biochem Biophys Res Commun; 1990 Oct 30; 172(2):793-9. PubMed ID: 2173580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.